NSB
GSK icon

Norway Savings Bank’s GSK GSK Stock Holding History

Norway Savings Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711K Buy
13,556
+832
+7% +$44K 0.3% 69
2026
Q1 		$702K Buy
12,724
+1,096
+9% +$59.4K 0.33% 68
2025
Q4 		$570K Buy
11,628
+1,412
+14% +$65.9K 0.26% 74
2025
Q3 		$441K Buy
10,216
+1,618
+19% +$63.2K 0.21% 80
2025
Q2 		$330K Buy
+8,598
New +$329K 0.17% 90
2023
Q1 		– Sell
-1,156
Closed -$40.6K – 196
2022
Q4 		$40.6K Hold
1,156
– – 0.02% 193
2022
Q3 		$34K Sell
1,156
-600
-34% -$22.7K 0.02% 203
2022
Q2 		$96K Hold
1,756
– – 0.05% 166
2022
Q1 		$96K Sell
1,756
-152
-8% -$8.26K 0.04% 171
2021
Q4 		$105K Sell
1,908
-1,218
-39% -$63.4K 0.05% 168
2021
Q3 		$149K Sell
3,126
-464
-13% -$23.3K 0.07% 155
2021
Q2 		$179K Sell
3,590
-3,460
-49% -$166K 0.09% 148
2021
Q1 		$315K Sell
7,050
-312
-4% -$14.2K 0.17% 113
2020
Q4 		$339K Sell
7,362
-80
-1% -$3.67K 0.19% 105
2020
Q3 		$350K Sell
7,442
-172
-2% -$8.62K 0.24% 90
2020
Q2 		$388K Buy
7,614
+2,692
+55% +$138K 0.29% 80
2020
Q1 		$233K Buy
4,922
+1,820
+59% +$97.1K 0.2% 97
2019
Q4 		$182K Sell
3,102
-240
-7% -$13.3K 0.13% 109
2019
Q3 		$178K Buy
3,342
+100
+3% +$5.14K 0.15% 104
2019
Q2 		$162K Hold
3,242
– – 0.14% 105
2019
Q1 		$169K Sell
3,242
-64
-2% -$3.2K 0.15% 104
2018
Q4 		$158K Buy
3,306
+428
+15% +$21.1K 0.15% 104
2018
Q3 		$145K Buy
2,878
+435
+18% +$22.1K 0.13% 108
2018
Q2 		$123K Buy
2,443
+739
+43% +$37.2K 0.11% 115
2018
Q1 		$83K Buy
1,704
+728
+75% +$33.9K 0.08% 136
2017
Q4 		$43K Sell
976
-1,480
-60% -$68.4K 0.04% 170
2017
Q3 		$125K Sell
2,456
-160
-6% -$8.12K 0.12% 116
2017
Q2 		$141K Hold
2,616
– – 0.14% 113
2017
Q1 		$138K Sell
2,616
-280
-10% -$14.2K 0.14% 108
2016
Q4 		$139K Buy
+2,896
New +$143K 0.13% 107

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Norway Savings Bank's GSK Position: Q2 2026 in Review

Norway Savings Bank increased its GSK (GSK) stake by 6.5% in Q2 2026, buying an estimated $44K and bringing the position to 13,556 shares worth $711K. The position accounts for 0.3% of the portfolio, ranked #69.

Norway Savings Bank first reported a position in GSK in Q4 2016 and has held it in 30 quarters since. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Norway Savings Bank held 13,556 shares of GSK worth $711K as of Q2 2026.
  • Norway Savings Bank bought 832 GSK shares in Q2 2026, an estimated $44K.
  • GSK made up 0.3% of Norway Savings Bank's portfolio in Q2 2026, its #69 holding.
  • Norway Savings Bank first reported a position in GSK in Q4 2016 and has held it in 30 quarters since.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Norway Savings Bank's 13F filing for Q2 2026, filed 8 Jul 2026.